Zhou M[au] - Search Results

Year	Number of Results
1979	2
1980	2
1981	5
1982	3
1983	1
1984	2
1985	5
1986	5
1987	10
1988	9
1989	9
1990	18
1991	29
1992	25
1993	30
1994	29
1995	48
1996	29
1997	49
1998	52
1999	53
2000	62
2001	62
2002	73
2003	109
2004	123
2005	146
2006	203
2007	249
2008	288
2009	294
2010	368
2011	388
2012	462
2013	621
2014	687
2015	855
2016	893
2017	984
2018	1155
2019	1264
2020	1520
2021	1885
2022	1959
2023	15

1

Sentinel p16^INK4a+ cells in the basement membrane form a reparative niche in the lung.

Reyes NS, Krasilnikov M, Allen NC, Lee JY, Hyams B, Zhou M, Ravishankar S, Cassandras M, Wang C, Khan I, Matatia P, Johmura Y, Molofsky A, Matthay M, Nakanishi M, Sheppard D, Campisi J, Peng T. Reyes NS, et al. Among authors: zhou m. Science. 2022 Oct 14;378(6616):192-201. doi: 10.1126/science.abf3326. Epub 2022 Oct 13. Science. 2022. PMID: 36227993

2

Towards Precision Genitourinary Pathology.

Zhou M. Zhou M. Surg Pathol Clin. 2022 Dec;15(4):xv-xvi. doi: 10.1016/j.path.2022.09.001. Epub 2022 Oct 13. Surg Pathol Clin. 2022. PMID: 36344190 No abstract available.

3

Induction of tumor cell autosis by myxoma virus-infected CAR-T and TCR-T cells to overcome primary and acquired resistance.

Zheng N, Fang J, Xue G, Wang Z, Li X, Zhou M, Jin G, Rahman MM, McFadden G, Lu Y. Zheng N, et al. Among authors: zhou m. Cancer Cell. 2022 Sep 12;40(9):973-985.e7. doi: 10.1016/j.ccell.2022.08.001. Epub 2022 Aug 25. Cancer Cell. 2022. PMID: 36027915

4

Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy.

Zhang Z, Chen L, Chen H, Zhao J, Li K, Sun J, Zhou M. Zhang Z, et al. Among authors: zhou m. EBioMedicine. 2022 Sep;83:104207. doi: 10.1016/j.ebiom.2022.104207. Epub 2022 Aug 9. EBioMedicine. 2022. PMID: 35961204 Free PMC article.

5

Immunotherapy for hepatocellular carcinoma.

Zhou M, Liu B, Shen J. Zhou M, et al. Clin Exp Med. 2022 Aug 24. doi: 10.1007/s10238-022-00874-5. Online ahead of print. Clin Exp Med. 2022. PMID: 36001163 Review.

6

Immune-Cell-Derived Exosomes for Cancer Therapy.

Zhao Y, Liu T, Zhou M. Zhao Y, et al. Among authors: zhou m. Mol Pharm. 2022 Sep 5;19(9):3042-3056. doi: 10.1021/acs.molpharmaceut.2c00407. Epub 2022 Jul 25. Mol Pharm. 2022. PMID: 35876318 Review.

7

Artificial Cells: Past, Present and Future.

Jiang W, Wu Z, Gao Z, Wan M, Zhou M, Mao C, Shen J. Jiang W, et al. Among authors: zhou m. ACS Nano. 2022 Oct 25;16(10):15705-15733. doi: 10.1021/acsnano.2c06104. Epub 2022 Oct 13. ACS Nano. 2022. PMID: 36226996 Review.

8

Advance in Hybrid Peptides Synthesis.

Zou J, Zhou M, Xiao X, Liu R. Zou J, et al. Among authors: zhou m. Macromol Rapid Commun. 2022 Aug 17:e2200575. doi: 10.1002/marc.202200575. Online ahead of print. Macromol Rapid Commun. 2022. PMID: 35978269

9

Synthesis of Subporphyrin Free Bases.

Liu L, Kim J, Xu L, Rao Y, Zhou M, Yin B, Oh J, Kim D, Osuka A, Song J. Liu L, et al. Among authors: zhou m. Angew Chem Int Ed Engl. 2022 Oct 13:e202214342. doi: 10.1002/anie.202214342. Online ahead of print. Angew Chem Int Ed Engl. 2022. PMID: 36227657

10

On-Surface Synthesis toward Two-Dimensional Polymers.

Niu T, Hua C, Zhou M. Niu T, et al. Among authors: zhou m. J Phys Chem Lett. 2022 Sep 1;13(34):8062-8077. doi: 10.1021/acs.jpclett.2c01481. Epub 2022 Aug 23. J Phys Chem Lett. 2022. PMID: 35997300 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results